TrialAmerican journal of clinical dermatology2023

Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials.

Linda Stein Gold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.